211 related articles for article (PubMed ID: 21775206)
21. Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.
Volanakis EJ; Williams RT; Sherr CJ
Blood; 2009 Nov; 114(20):4451-9. PubMed ID: 19759355
[TBL] [Abstract][Full Text] [Related]
22. The role of NOTCH1 signaling in T-ALL.
Ferrando AA
Hematology Am Soc Hematol Educ Program; 2009; ():353-61. PubMed ID: 20008221
[TBL] [Abstract][Full Text] [Related]
23. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
24. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
25. Notch in Leukemia.
McCarter AC; Wang Q; Chiang M
Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
[TBL] [Abstract][Full Text] [Related]
26. [Research advance on the pathogenesis of T-ALL induced by notch 1 activating mutations].
Xu SN; Chen JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):242-5. PubMed ID: 20137156
[TBL] [Abstract][Full Text] [Related]
27. Notch signaling expands a pre-malignant pool of T-cell acute lymphoblastic leukemia clones without affecting leukemia-propagating cell frequency.
Blackburn JS; Liu S; Raiser DM; Martinez SA; Feng H; Meeker ND; Gentry J; Neuberg D; Look AT; Ramaswamy S; Bernards A; Trede NS; Langenau DM
Leukemia; 2012 Sep; 26(9):2069-78. PubMed ID: 22538478
[TBL] [Abstract][Full Text] [Related]
28. A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development.
Klein-Hessling S; Rudolf R; Muhammad K; Knobeloch KP; Maqbool MA; Cauchy P; Andrau JC; Avots A; Talora C; Ellenrieder V; Screpanti I; Serfling E; Patra AK
Nat Commun; 2016 Jun; 7():11841. PubMed ID: 27312418
[TBL] [Abstract][Full Text] [Related]
29. ARRB1-Promoted NOTCH1 Degradation Is Suppressed by OncomiR miR-223 in T-cell Acute Lymphoblastic Leukemia.
Shu Y; Wang Y; Lv WQ; Peng DY; Li J; Zhang H; Jiang GJ; Yang BJ; Liu S; Zhang J; Chen YH; Tang S; Wan KX; Yuan JT; Guo W; Fu G; Qi XK; Liu ZD; Liu HY; Yang C; Zhang LH; Liu FJ; Yu J; Zhang PH; Qu B; Zhao H; He TC; Zou L
Cancer Res; 2020 Mar; 80(5):988-998. PubMed ID: 31822496
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Mavrakis KJ; Wolfe AL; Oricchio E; Palomero T; de Keersmaecker K; McJunkin K; Zuber J; James T; Khan AA; Leslie CS; Parker JS; Paddison PJ; Tam W; Ferrando A; Wendel HG
Nat Cell Biol; 2010 Apr; 12(4):372-9. PubMed ID: 20190740
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetics of acute lymphoblastic leukemia.
Teitell MA; Pandolfi PP
Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
[TBL] [Abstract][Full Text] [Related]
32. An activating intragenic deletion in NOTCH1 in human T-ALL.
Haydu JE; De Keersmaecker K; Duff MK; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Ferrando A
Blood; 2012 May; 119(22):5211-4. PubMed ID: 22510873
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
[TBL] [Abstract][Full Text] [Related]
34. Growth factor independent-1 maintains Notch1-dependent transcriptional programming of lymphoid precursors.
Phelan JD; Saba I; Zeng H; Kosan C; Messer MS; Olsson HA; Fraszczak J; Hildeman DA; Aronow BJ; Möröy T; Grimes HL
PLoS Genet; 2013; 9(9):e1003713. PubMed ID: 24068942
[TBL] [Abstract][Full Text] [Related]
35. Notch signaling in leukemia.
Aster JC; Pear WS; Blacklow SC
Annu Rev Pathol; 2008; 3():587-613. PubMed ID: 18039126
[TBL] [Abstract][Full Text] [Related]
36. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression.
Tsaouli G; Ferretti E; Bellavia D; Vacca A; Felli MP
J Immunol Res; 2019; 2019():5601396. PubMed ID: 31346528
[TBL] [Abstract][Full Text] [Related]
37. T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF
Haematologica; 2019 May; 104(5):e204-e207. PubMed ID: 30514801
[No Abstract] [Full Text] [Related]
38. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia.
Gao J; Van Meter M; Hernandez Lopez S; Chen G; Huang Y; Ren S; Zhao Q; Rojas J; Gurer C; Thurston G; Kuhnert F
Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399482
[TBL] [Abstract][Full Text] [Related]
40. Placing ion channels into a signaling network of T cells: from maturing thymocytes to healthy T lymphocytes or leukemic T lymphoblasts.
Dobrovinskaya O; Delgado-Enciso I; Quintero-Castro LJ; Best-Aguilera C; Rojas-Sotelo RM; Pottosin I
Biomed Res Int; 2015; 2015():750203. PubMed ID: 25866806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
